Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer

International Journal of Gynecological Cancer

Volumn 15, Issue 5, 2005, Pages 926-931

  Cengiz, M ^a   Singh, A K ^b   Grigsby, Perry W ^b,c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

Author keywords

Brachytherapy; Endometrial cancer; External radiotherapy; Toxicity

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; SURVIVAL RATE; VAGINAL NEOPLASMS;

EID: 28044438558     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00156.x     Document Type: Article

References (20)

1. Creasman WT, Odicino F, Maisonneuve P et al. Carci-noma of the corpus uteri. J Epidemiol Biostat 2001;6:47-86.
2. Shepherd J. Revised FIGO staging for gynaecological cancer. BJOG 1989;96:889-92.
3. Aalders JG, vd Syde R, Poppema S, Szabo BG, Janssens J. Prognostic factors and changing trends in the treatment of stage I endometrial cancer: a clinical and histopathological study of 182 patients. Int J Radiat Oncol Biol Phys 1984;10:2083-8.
4. Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 2000;355:1404-11.
5. Rose PG. Endometrial carcinoma. N Engl J Med 1996;335:640-9.
6. Roberts JA, Brunetto VL, Keys HM et al. A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOG 99) [abstract]. Gynecol Oncol 1998;68:135.
7. Grigsby PW, Perez CA, Kuten A et al. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys 1992;22:905-11.
8. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
9. Straughn JM, Huh WK, Orr JW Jr et al. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 2003;89:295-300.
10. Perez CA, Brady LW. Overview. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, 2nd edn. Philadelphia, PA: JB Lippincott, 1992:51-5.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
13. Straughn JM Jr, Huh WK, Kelly FJ et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 2002;84:194-200.
14. Orr JW Jr, Holimon JL, Orr PF. Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 1997;176:777-88; discussion 788-9.
15. Larson DM, Broste SK, Krawisz BR. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 1998;91:355-9.
16. Barnes MN, Roland PY, Straughn M, Kilgore LC, Alvarez RD, Partridge EE. A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact. Gynecol Oncol 1999;74:443-7.
17. Creutzberg CL, van Putten WL, Koper PC et al. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys 2001;51:1246-55.
18. Fanning J. Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 2001;82:371-4.
19. Chadha M, Nanavati PJ, Liu P, Fanning J, Jacobs A. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 1999;75:103-7.
20. Pearcey RG, Petereit DG. Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiother Oncol 2000;56:17-22.